Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca 2+-ATPase

Pharmacology

Volumn 81, Issue 4, 2008, Pages 325-332

  Xu, Xiao Le ^a   Chen, Xiang Jian ^b   Ji, Hui ^a   Li, Ping ^a   Bian, Yun Yun ^a   Yang, Di ^b   Xu, Jin Dan ^b   Bian, Zhi Ping ^b   Zhang, Ji Nan ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Astragaloside IV; Hypoxia reoxygenation; Intracellular calcium; Sarcoplasmic reticulum

Indexed keywords

ASTRAGALOSIDE IV; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TROPONIN I;

ANIMAL CELL; ARTICLE; ASTRAGALUS MEMBRANACEUS; CALCIUM CELL LEVEL; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; GENE EXPRESSION; GENE SEQUENCE; HEART CELL CULTURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HYPOXIA; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ASTRAGALUS MEMBRANACEUS; CALCIUM; CELL HYPOXIA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT DYES; FURA-2; GENE EXPRESSION REGULATION; MYOCYTES, CARDIAC; OXYGEN; RATS; RNA, MESSENGER; SAPONINS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRITERPENES;

EID: 43449089788     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121335     Document Type: Article

References (27)

1. 2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur J Pharmacol 2006;535:212-219.
2. Zucchi R, Ronca F, Ronca-Testoni S: Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther 2001;89:47-65.
3. Gianni D, Chan J, Gwathmey JK, del Monte F, Hajjar RJ: SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr 2005;37:375-380.
4. 2+ handling in failing human myocardium. J Mol Cell Cardiol 2001;33:1345-1353.
5. Schmidt U, Hajjar RJ, Helm PA, Kim CS, Doye AA, Gwathmey JK: Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J Mol Cell Cardiol 1998;30:1929-1937.
6. Muller OJ, Lange M, Rattunde H, Lorenzen HP, Muller M, Frey N, Bittner C, Simonides W, Katus HA, Franz WM: Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 2003;59:380-389.
7. Han L, Chen K: Progress of experimental pharmacologic study on the effect of Astragaus on the cardiacvascular system. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000;20:234-237.
8. Miller AL: Botanical influences on cardiovascular disease. Altern Med Rev 1998;3:422-431.
9. 2+ overload. Am J Physiol Heart Circ Physiol 2005;288:H1900-H1908.
10. Zhou JY, Fan Y, Kong JL, Wu DZ, Hu ZB: Effects of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats. Zhongguo Zhong Yao Za Zhi 2000;25:300-302.
11. Zhang WD, Chen H, Zhang C, Liu RH, Li HL, Chen HZ: Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med 2006;72:4-8.
12. Chlopcikova S, Psotova J, Miketova P: Neonatal rat cardiomyocytes - a model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2001;145:49-55.
13. Rui T, Feng Q, Lei M, Peng T, Zhang J, Xu M, Abel ED, Xenocostas A, Kvietys PR: Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res 2005;65:719-727.
14. Chanalaris A, Sun Y, Latchman DS, Stephanou A: SAG attenuates apoptotic cell death caused by simulated ischaemia/reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol 2003;35:257-264.
15. Chen XJ, Bian ZP, Lu S, Xu JD, Gu CR, Yang D, Zhang JN: Cardiac protective effect of Astragalus on viral myocarditis mice: comparison with Perindopril. Am J Chin Med 2006;34:493-502.
16. Ozaki H, Zaizen H, Kiyosue T, Nasu M, Arita M: Effect of bepridil on intracellular calcium concentration and contraction in cultured rat ventricular myocytes. J Cardiovasc Pharmacol 1999;33:492-499.
17. Ren J, Porter JE, Wold LE, Aberle NS, Muralikrishnan D, Haselton JR: Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse. Neurobiol Aging 2004;25:131-138.
18. Chen XJ, Meng D, Feng L, Bian YY, Li P, Yang D, Cao KJ, Zhang JN: Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats. Am J Chin Med 2006;34:1015-1025.
19. 2+-dependent pNPPase: age-dependent changes. Basic Res Cardiol 1995;90:323-331.
20. 2+-ATPase of viral myocarditis mice. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999;19:672-674.
21. Meng D, Chen XJ, Bian YY, Li P, Yang D, Zhang JN: Effect of astragalosides on intracellular calcium overload in cultured cardiac myocytes of neonatal rats. Am J Chin Med 2005;33:11-20.
22. O'Brien PJ, Smith DE, Knechtel TJ, Marchak MA, Pruimboom-Brees I, Brees DJ, et al: Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim 2006;40:153-171.
23. Zhou S, Shao W, Zhang W: Clinical study of Astragalus injection plus ligustrazine in protecting myocardial ischemia reperfusion injury. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000;20:504-507.
24. Li ZP, Cao Q: Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol Sin 2002;23:898-904.
25. Bassani JW, Bassani RA, Bers DM: Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J Physiol 1994;476:279-293.
26. 2+ content in permeabilized cardiac myocytes. Circ Res 2001;89:526-533.
27. Takeo S, Elmoselhi AB, Goel R, Sentex E, Wang J, Dhalla NS: Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil. Mol Cell Biochem 2000;213:111-118.